No Data
No Data
Wedbush Keeps Their Buy Rating on Generation Bio (GBIO)
Generation Bio Is Maintained at Buy by Canaccord Genuity
Generation Bio Price Target Maintained With a $9.00/Share by Canaccord Genuity
Generation Bio Co.'s (NASDAQ:GBIO) 29% Dip In Price Shows Sentiment Is Matching Revenues
Generation Bio Co. Advances in Autoimmune Therapeutics
JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating